Magic Mushrooms For The Treatment of Depression

Depression and suicide are significant public health concerns. Our current therapies are not as effective as we would want. Incidences of suicide are rising. There is an urgent need for effective and innovative treatments for depression.

Suicidality may be prevented by some psychedelics. Both patients and doctors will struggle to get past the stigma attached to their use. A similar issue continues to prevent medical marijuana from becoming widely accepted.

More than 75 different species of mushrooms contain psilocybin, a promising psychedelic; the most well-known of these is Psilocybe Mexicana, often known as the "Magic Mushroom." Following ingestion, psilocybin spontaneously converts into psilocin, a more lipid-soluble psychedelic. Recent PET studies suggest that the psychedelic effects of psilocin are due to its ability to activate the 5HT2A serotonin receptor. Psilocybin has so far only demonstrated limited efficacy, despite some authors' claims of positive results in clinical trials for the treatment of addiction, depression, post-traumatic stress disorder, and death fear.

Many species of the Psilocybe mushroom also include a range of tryptophan-derived beta-carbolines, such as harmane and harmine, which may also have advantageous effects on brain function. Why do the effects of psilocybe mushrooms depend so heavily on beta-carbolines? Psilocin is rendered inactive by the monoamine oxidase enzyme, which is strongly inhibited by beta-carbolines. This behaviour can be found in any plant or fungus, and it is noteworthy. By using unique pathways that diverge from the same building block, tryptophan, the psilocybe produces a wide spectrum of different natural chemicals, all of which either directly or indirectly contribute to the same pharmacological effects.

Understanding why that is the case requires understanding the role of 5HT2A receptors in the brain. Drug addiction, depression/anxiety, and schizophrenia, for example, may all be brought on by abnormalities in the design and functionality of the 5HT2A receptors. The treatment of several disorders involves the use of drugs that block 5HT2A receptors. Let me reiterate that last statement: The effects of psilocybin are the exact reverse of those of antidepressants and anxiety medicines!

Cultural Change

The legalisation of formerly illegal drugs for medicinal use has made the use of psychedelics for therapeutic purposes viable. Recent events, including as the FDA's recent rescheduling of esketamine1 (the first authorised psychedelic) for the treatment of TRD, and the legalisation of marijuana, highlight this cultural shift (Krupitsky & Grinenko, 1997).

The fast pace of research and the rapidly growing body of knowledge may soon revolutionise how we treat and manage mental diseases. The rebirth of interest in psychedelics has made it possible to do research on a variety of ailments.

Comments

Popular posts from this blog

How To Grow Dried Mushroom

MAGIC MUSHROOM SPORES CALIFORNIA